A retrospective real-world study of nimotuzumab combined with chemotherapy for first-line treatment of advanced pancreatic cancer: A single center propensity score matched analysis

被引：0
|
作者：
Wu, Y. [1 ]
Dong, X. [2 ]
Li, E. [1 ]
Fan, Y. [2 ]
Dong, D. [3 ]
Shi, Y. [3 ]
Wang, M. [4 ]
Yang, N. [4 ]
Ou, F. [4 ]
Wang, J. [4 ]
Yang, Y. [4 ]
机构：
[1] Xi An Jiao Tong Univ, Med Coll, Affiliated Hosp 1, Med Oncol Dept, Xian, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 1, Med Oncol, Xian, Peoples R China
[3] Xi An Jiao Tong Univ, Med Oncol, Xian, Peoples R China
[4] Xi An Jiao Tong Univ, Med Oncol, Sch Med, Xian, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2625
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1678P
引用
收藏
页码：S920 / S920
页数：1
相关论文
共 50 条
  • [31] Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer
    Blomstrand, Hakon
    Batra, Atul
    Cheung, Winson Y.
    Elander, Nils Oskar
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (09): : 787 - 799
  • [32] The Safety and Efficacy of Cadonilimab in the First-Line Treatment of Recurrent or Metastatic Cervical Cancer: A Retrospective, Real-World Study
    Jin, G.
    Wang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E693 - E693
  • [33] PD-L1 Inhibitors Combined with Thoracic Radiotherapy in First-Line Treatment of Extensive Stage Small Cell Lung Cancer: A Propensity Score-Matched, Real -World Study
    Peng, J.
    Zhang, L.
    Wang, L.
    Feng, H.
    Yao, D.
    Meng, R.
    Liu, X.
    Li, X.
    Liu, N.
    Tan, B.
    Huang, Z.
    Li, S.
    Meng, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S127 - S128
  • [34] Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer
    Pelicon, Veronika
    Cufer, Tanja
    Knez, Lea
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [35] Prognostic analysis of nimotuzumab combined with concurrent chemoradiotherapy in locally advanced cervical cancer: A multicenter real-world study
    Li, Jiwei
    Wu, Tao
    Cai, Manbo
    Xie, Changjun
    Ding, Sijuan
    Zou, Wen
    Wang, Jingjing
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [36] A Real-World Study of Optimal Treatment with Anlotinib First-Line Therapy in Advanced Hepatocellular Carcinoma
    Li, Qingqing
    Su, Tong
    Zhang, Xu
    Pan, Yanfeng
    Ma, Shengli
    Zhang, Lu
    Zhang, Xianqiang
    Gao, Xiaojuan
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3037 - 3046
  • [37] Real-world first-line treatment patterns and outcomes in hormone-receptor positive advanced breast cancer patients: A multicenter, retrospective study
    Chen, Z.
    Wang, X.
    Ouyang, Q.
    Tian, C.
    Wang, Y.
    Wang, H.
    Wang, J.
    Liang, H.
    Wang, C.
    Wu, X.
    Zhang, Y.
    Zhang, P.
    Ren, D.
    Huang, J.
    Zheng, Y.
    Cao, W.
    Shao, X.
    ANNALS OF ONCOLOGY, 2021, 32 : S465 - S466
  • [38] Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis
    Riedl, J. M.
    Posch, F.
    Horvath, L.
    Gantschnigg, A.
    Renneberg, F.
    Schwarzenbacher, E.
    Moik, F.
    Barth, D.
    Stotz, M.
    Schaberl-Moser, R.
    Pichler, M.
    Stoeger, H.
    Greil, R.
    Djanani, A.
    Schlick, K.
    Gerger, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S942 - S942
  • [39] Nimotuzumab combined with chemotherapy plus immunotherapy as first-line treatment for advanced esophageal squamous cell carcinoma.
    Han, Quanli
    Wang, Qi
    Cui, Zhi
    Deng, Muhong
    Ma, Yue
    Pang, Fang
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 344 - 344
  • [40] Understanding real-world treatment patterns of patients with advanced ovarian cancer in the first-line maintenance setting: The FIRST STEP Study
    Cooney, Maureen
    Kalilani, Linda
    Kiss, Zsofia
    Golembesky, Amanda
    Kobayashi, Monica
    Dayma, Megha
    Coskuncay, Elif
    Schilder, Jeanne
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S202 - S203
12345